Researching the functions and expressions of ERBB3 isoforms is important for creating targeted therapies and improving patient outcomes in renal cell carcinoma (RCC), a type of cancer that has a very complex genetic landscape. Here, ERBB3 is linked to hereditary clear cell renal cell carcinoma.